Ipratropium bromide/salbutamol (Respimat)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ipratropium bromide/salbutamol (Respimat), covering 2014-06-27 to 2014-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Phase 3]